Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles (Q42494908)

1 November 2017

Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles (English)

1 reference

1 November 2017

Ebner T

1

1 reference

1 November 2017

Sommergruber M

2

1 reference

1 November 2017

Moser M

3

1 reference

1 November 2017

Shebl O

4

1 reference

1 November 2017

Schreier-Lechner E

5

1 reference

1 November 2017

Tews G

6

1 reference

1 November 2017

language of work or name

English

0 references

publication date

5 May 2006

1 reference

1 November 2017

1 reference

1 November 2017

21

1 reference

1 November 2017

2022-2026

1 reference

1 November 2017

8

1 reference

Oocyte quality in patients with severe ovarian hyperstimulation syndrome

1 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Biological versus chronological ageing of oocytes, distinguishable by raised FSH levels in relation to the success of IVF treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-müllerian hormone and anti-müllerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Isolation of the bovine and human genes for Müllerian inhibiting substance and expression of the human gene in animal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Antimüllerian hormone serum levels: a putative marker for ovarian aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

A prospective study on oocyte survival rate after ICSI: influence of injection technique and morphological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Selection based on morphological assessment of oocytes and embryos at different stages of preimplantation development: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Presence, but not type or degree of extension, of a cytoplasmic halo has a significant influence on preimplantation development and implantation behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Serum anti-Müllerian hormone dynamics during controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Serum anti-Müllerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH and LH on day 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

High reproducibility of serum anti-Mullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Per-follicle measurements indicate that anti-müllerian hormone secretion is modulated by the extent of follicular development and luteinization and may reflect qualitatively the ovarian follicular status

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-Müllerian hormone and its role in ovarian function

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-Müllerian hormone plasma levels in spontaneous menstrual cycle and during treatment with FSH to induce ovulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Antral follicle count, anti-mullerian hormone and inhibin B: predictors of ovarian response in assisted reproductive technology?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

The relationship between pregnancy outcome and smooth endoplasmic reticulum clusters in MII human oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Early follicular serum müllerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Mullerian inhibiting substance levels at the time of HCG administration in IVF cycles predict both ovarian reserve and embryo morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

The variability of female reproductive ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-mullerian hormone as a marker of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEL127

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEL127

1 reference

1 November 2017

1 reference